Coverage
-
March 31, 2026
A New York federal judge has ruled that Quantum BioPharma Ltd. can pursue most of its lawsuit accusing the brokerage arms of the Royal Bank of Canada and the Canadian Imperial Bank of Commerce of spoofing the biopharmaceutical company's stock, finding that Quantum plausibly alleged that the scheme occurred and that the banks acted recklessly.
1 other articles on this case.
View all »